Loading clinical trials...
Loading clinical trials...
In this study, a prospective, randomized and controlled clinical study would be carried out to establish Ultrasound Integrated Precision Diagnosis Technology with elastography as the core technology to evaluate renal injury and repair comprehensively and accurately, and to improve the clinical diagnosis chance of renal injury (or renal fibrosis). Combined with the dynamic changes of biomarkers (inflammatory factors, cytokines secreted by immune cells, etc.) after kidney injury, the research on the prognosis of kidney disease with ultrasound elastography technology as the core would be explored, which aims to provide a scientific basis for the application of Ultrasound Integrated Precision Diagnosis Technology.
Age
18 - 70 years
Sex
ALL
Healthy Volunteers
No
Department of nephrology , Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine
Shanghai, Shanghai Municipality, China
China-Japan Friendship Hospital
Beijing, China
Start Date
April 29, 2019
Primary Completion Date
May 29, 2021
Completion Date
June 30, 2021
Last Updated
November 27, 2023
208
ACTUAL participants
Ultrasound Integrated Precision Diagnosis Technology(ultrasound elastography)
DIAGNOSTIC_TEST
Lead Sponsor
RenJi Hospital
Collaborators
NCT07241390
NCT04634916
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions